ROCK1 and Obesity: Overall, the L-CA-ROCK1 phenotype demonstrates a possible causal role of hepatic ROCK1 overactivity in metabolic disease pathologies, identifying a potential therapeutic target in liver ROCK1 to treat obesity and diabetes.